RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/28479
https://w3id.org/ripe/ripe-kg/retraction-notice/28479
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA0C83AF9CE6274D42 |
prov:used |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA22B2228793442254 |
prov:used |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA3DB7B5186353EACB |
prov:used |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA4BED4D9BD987577D |
prov:used |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:evaluation/RIPEA69C9C09037F4A7D7 |
prov:used |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prism:doi |
10.1080/0167482x.2020.1842508 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prism:publicationDate |
2020-11-03 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prism:publicationName |
Journal of Psychosomatic Obstetrics & Gynecology |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
dcterms:publisher |
ripekg:publisher/RIPEP08117F3F6484319BTaylor and Francis |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
dcterms:title |
Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1080%2F0167482x.2017.1383381 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
owl:Thing |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
owl:sameAs |
https://semopenalex.org/work/W4256205189 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA0C83AF9CE6274D42 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA22B2228793442254 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA3DB7B5186353EACB |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4BED4D9BD987577D |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA69C9C09037F4A7D7 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA0C83AF9CE6274D42 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA22B2228793442254 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA3DB7B5186353EACB |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA4BED4D9BD987577D |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA69C9C09037F4A7D7 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAU1712756B1250D256Fatemeh Foroozanfard |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUC4F4857955665209Hamidreza Jamilian |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:author/RIPEAUFF859281894E1520Faraneh Afshar Ebrahimi |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:work/10.1080%2F0167482x.2017.1383381 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:rationale |
Concerns/Issues About Data;Investigation by Company/Institution;Updated to Retraction |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:retractionWatchRecordId |
28479 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-human-1-3 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-inspectai-1-3 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA22B2228793442254-human-1-3 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA22B2228793442254-inspectai-1-3 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-human-1-3 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-inspectai-1-3 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-human-1-3 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-inspectai-1-3 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-human-1-3 |
ripekg:retraction-notice/28479Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-inspectai-1-3 |